Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-319-2
CAS number: 94-28-0
Individual Clinical Observations and
Effects Noted After Dosing
Effects Noted During Period After Dosing
a sighting test in which there was no mortality at a dose level of 2000
mg/kg, an additional four fasted female animals were given a single oral
dose of undiluted test material, at a dose level of 2000 mg/kg. Clinical
signs and bodyweight development were monitored during the study. There
were no deaths, nor
of systemic toxicity. All animals showed expected gains in bodyweight,
and no abnormalities were noted at necropsy. The acute oral median
lethal dose (LD50) of the test material in the female Sprague-Dawley CD
strain rat was estimated to be greater than 2000 mg/kg bodyweight
(Globally Harmonised Classification System - Unclassified).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again